The 5 analysts offering 12-month price forecasts for Milestone Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +118.75% increase from the last price of 6.40.
The current consensus among 5 polled investment analysts is to Buy stock in Milestone Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.38
Reporting Date Nov 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.